Skip to main content

Advertisement

SpringerLink
Log in

Breast cancer and aging: results of the U13 conference breast cancer panel

  • Review
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Breast cancer is predominantly a disease of older women, yet there is a knowledge gap due to the persisting misalignment between the age distribution of women with breast cancer and the age distribution of participants in clinical trials. The purpose of this report is to state the U13 conference breast cancer panel’s recommendations regarding therapeutic clinical trials that will fill gaps in knowledge regarding the care of older patients with breast cancer. The U13 conference was a collaboration between the Cancer and Aging Research Group and the National Institute on Aging and the National Cancer Institute (NCI). Clinical trials should be developed for frail and vulnerable patients who would not enroll on the standard phase III trials, as well as efforts need to be made to increase enrollment of fit older patients on standard phase III trials. As a result of this conference, panel members are working with the NCI and cooperative groups to address these knowledge gaps. With the aging population and increasing incidence of breast cancer with age, it is essential to study the feasibility, toxicity, and efficacy of cancer therapy in this at-risk population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Desantis C, Siegel R, Bandi P et al (2011) Breast cancer statistics. CA Cancer J Clin 61:409–418

    Article  PubMed  Google Scholar 

  2. Siegel R, DeSantis C, Virgo K et al (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62:220–241

    Article  PubMed  Google Scholar 

  3. Smith BD, Smith GL, Hurria A et al (2009) Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 27:2758–2765

    Article  PubMed  Google Scholar 

  4. McDermott AM, Toelle TR, Rowbotham DJ et al (2006) The burden of neuropathic pain: results from a cross-sectional survey. Eur J Pain 10:127–135

    Article  PubMed  Google Scholar 

  5. McDonald M, Hertz RP, Unger AN et al (2009) Prevalence, awareness, and management of hypertension, dyslipidemia, and diabetes among United States adults aged 65 and older. J Gerontol A Biol Sci Med Sci 64:256–263

    Article  PubMed  Google Scholar 

  6. Owusu C, Hurria A, Muss H (2012) Adjuvant therapy for older women with early-stage breast cancer: treatment selection in a complex population. Am Soc Clin Oncol Educ Book 32:3–9

    Google Scholar 

  7. Minino AM, Murphy SL (2012) Death in the United States, 2010. NCHS Data Brief 1–8

  8. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717

    Article  Google Scholar 

  9. van de Water W, Markopoulos C, van de Velde CJ et al (2012) Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer. JAMA 307:590–597

    Google Scholar 

  10. Lichtman SM, Wildiers H, Chatelut E et al (2007) International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients–an analysis of the medical literature. J Clin Oncol 25:1832–1843

    Article  CAS  PubMed  Google Scholar 

  11. Kemeny MM, Peterson BL, Kornblith AB et al (2003) Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol 21:2268–2275

    Article  PubMed  Google Scholar 

  12. Kimmick GG, Muss HB (2001) Systemic therapy for older women with breast cancer. Oncology (Williston Park) 15:280–291; discussion 291–292, 295–296, 299

  13. Muss HB, Woolf S, Berry D et al (2005) Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 293:1073–1081

    Article  CAS  PubMed  Google Scholar 

  14. Lichtman SM, Skirvin JA (2000) Pharmacology of antineoplastic agents in older cancer patients. Oncology (Williston Park) 14:1743–1755; discussion 1755, passim

  15. Ramjaun A, Nassif MO, Krotneva S et al (2013) Improved targeting of cancer care for older patients: a systematic review of the utility of comprehensive geriatric assessment. J Geriatr Oncol 4:271–281

    Article  PubMed  Google Scholar 

  16. Wildes TM, Ruwe AP, Fournier C et al (2013) Geriatric assessment is associated with completion of chemotherapy, toxicity, and survival in older adults with cancer. J Geriatr Oncol 4:227–234

    Article  PubMed  Google Scholar 

  17. Citron ML, Berry DA, Cirrincione C et al (2003) Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. J Clin Oncol 21:1431–1439

    Article  CAS  PubMed  Google Scholar 

  18. Hurria A, Togawa K, Mohile SG et al (2011) Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 29:3457–3465

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Pinder MC, Duan Z, Goodwin JS et al (2007) Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. J Clin Oncol 25:3808–3815

    Article  CAS  PubMed  Google Scholar 

  20. Thomas ES, Gomez HL, Li RK et al (2007) Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment. J Clin Oncol 25:5210–5217

    Article  CAS  PubMed  Google Scholar 

  21. Baselga J, Campone M, Piccart M et al (2012) Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. N Engl J Med 366:520–529

    Article  CAS  PubMed  Google Scholar 

  22. Bunnell C, Vahdat L, Schwartzberg L et al (2008) Phase I/II study of ixabepilone plus capecitabine in anthracycline-pretreated/resistant and taxane-resistant metastatic breast cancer. Clin Breast Cancer 8:234–241

    Article  CAS  PubMed  Google Scholar 

  23. Cortes J, O’Shaughnessy J, Loesch D et al (2011) Eribulin monotherapy versus treatment of physician’s choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study. Lancet 377:914–923

    Article  CAS  PubMed  Google Scholar 

  24. Blackwell KL MD, Gianni L, et al (2012) Primary results from EMILIA, a phase 3 study of trastuzumab emtansine (T-DM1) vs capecitabine and lapatinib in HER2-positive locally advanced or metastatic breast cancer previously treated with trastuzumab and a taxane. 2012 ASCO Annual Meeting. Abstract LBA1. Presented June 3

  25. Baselga J, Cortes J, Kim SB et al (2012) Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer. N Engl J Med 366:109–119

    Article  CAS  PubMed  Google Scholar 

  26. Geyer CE, Forster J, Lindquist D et al (2006) Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J Med 355:2733–2743

    Article  CAS  PubMed  Google Scholar 

  27. Schwartzberg LS, Franco SX, Florance A et al (2010) Lapatinib plus letrozole as first-line therapy for HER-2 + hormone receptor-positive metastatic breast cancer. Oncologist 15:122–129

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

The study was supported by the U13 conference grant (U13 AG038151). The study sponsors were not involved in the writing of the article or the decision to submit it for publication. The authors were independent from study sponsors.

Author information

Authors and Affiliations

  1. Hofstra-North Shore LIJ School of Medicine, North Shore-LIJ Cancer Institute, 450 Lakeville Road, Lake Success, NY, 11042, USA

    M. F. Barginear, H. Muss, G. Kimmick, C. Owusu, E. Mrozek, A. Shahrokni, K. Ballman & A. Hurria

  2. UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA

    H. Muss

  3. Duke University Medical Center, Durham, NC, USA

    G. Kimmick

  4. Case Western Reserve University School of Medicine, Cleveland, Ohio, USA

    C. Owusu

  5. The Ohio State University, Columbus, OH, USA

    E. Mrozek

  6. Memorial Sloan Kettering Cancer Center, NY, USA

    A. Shahrokni

  7. Mayo Clinic, Rochester, MN, USA

    K. Ballman

  8. City of Hope Comprehensive Cancer Center, Duarte, CA, USA

    A. Hurria

Authors
  1. M. F. Barginear
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Muss
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Kimmick
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Owusu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Mrozek
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Shahrokni
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. K. Ballman
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A. Hurria
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. F. Barginear.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Barginear, M.F., Muss, H., Kimmick, G. et al. Breast cancer and aging: results of the U13 conference breast cancer panel. Breast Cancer Res Treat 146, 1–6 (2014). https://doi.org/10.1007/s10549-014-2994-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-014-2994-7

Keywords

Search

Navigation